Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

CRMD

CorMedix (CRMD)

CorMedix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRMD
DateTimeSourceHeadlineSymbolCompany
06/06/202422:30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants Pass-Through Status to DefencathNASDAQ:CRMDCorMedix Inc
23/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CRMDCorMedix Inc
14/05/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
10/05/202407:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRMDCorMedix Inc
09/05/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRMDCorMedix Inc
09/05/202421:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
19/04/202422:30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants TDAPA to DefenCathNASDAQ:CRMDCorMedix Inc
15/04/202422:30GlobeNewswire Inc.CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)NASDAQ:CRMDCorMedix Inc
12/03/202422:30GlobeNewswire Inc.CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
31/01/202409:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
19/01/202408:53Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CRMDCorMedix Inc
18/01/202412:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
18/01/202412:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
18/01/202412:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
18/01/202412:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
16/12/202300:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
15/12/202308:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
15/12/202308:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
22/11/202308:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
17/11/202308:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
15/11/202308:05GlobeNewswire Inc.CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
31/10/202307:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
11/10/202323:30GlobeNewswire Inc.CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek ConferenceNASDAQ:CRMDCorMedix Inc
14/09/202307:26Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CRMDCorMedix Inc
14/09/202307:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CRMDCorMedix Inc
14/09/202307:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CRMDCorMedix Inc
09/09/202306:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
08/09/202322:30GlobeNewswire Inc.CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of NephrologyNASDAQ:CRMDCorMedix Inc
30/08/202322:00GlobeNewswire Inc.CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product DefencathNASDAQ:CRMDCorMedix Inc
17/08/202322:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
 Showing the most relevant articles for your search:NASDAQ:CRMD